Common variants of ACE contribute to variable age-at-onset of Alzheimer's disease

Human Genetics

Volumn 114, Issue 5, 2004, Pages 478-483

  Kehoe, Patrick G ^a   Katzov, Hagit ^b   Andreasen, Niels ^c   Gatz, Maragaret ^d   Wilcock, Gordon K ^a   Cairns, Nigel J ^e   Palmgren, Juni ^b,f   de Faire, Ulf ^b   Brookes, Anthony J ^b   Pedersen, Nancy L ^b   Blennow, Kaj ^g   Prince, Jonathan A ^b  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b KAROLINSKA INSTITUTE   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^e KING'S COLLEGE LONDON   (United Kingdom)

^f STOCKHOLM UNIVERSITY   (Sweden)

^g SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E4; DIPEPTIDYL CARBOXYPEPTIDASE; ENZYME VARIANT; NUCLEOTIDE;

ADULT; AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DATA ANALYSIS; ENZYME BLOOD LEVEL; EUROPE; EXON; FEMALE; GENE LOCATION; GENE LOCUS; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC MODEL; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROPATHOLOGY; ONSET AGE; POPULATION RESEARCH; PRIORITY JOURNAL; PROMOTER REGION; SAMPLING; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL ANALYSIS; ANALYSIS OF VARIANCE; COMPARATIVE STUDY; GENETIC SCREENING; GENETICS; SWEDEN; UNITED KINGDOM;

AGE OF ONSET; ALLELES; ALZHEIMER DISEASE; ANALYSIS OF VARIANCE; CASE-CONTROL STUDIES; GENETIC SCREENING; GREAT BRITAIN; HUMANS; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, SINGLE NUCLEOTIDE; SWEDEN; VARIATION (GENETICS);

EID: 2542497904     PISSN: 03406717     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00439-004-1093-y     Document Type: Article

References (27)

1. Abecasis GR, Cookson WO, Cardon LR (2000) Pedigree tests of transmission disequilibrium. Eur J Hum Genet 8:545-551
2. Andreasen N, Blennow K, Sjodin C, Winblad B, Svardsudd K (1999) Prevalence and incidence of clinically diagnosed memory impairments in a geographically defined general population in Sweden. The Pitea Dementia Project. Neuroepidemiology 18:144-155
3. Andreasen N, Vanmechelen E, Vanderstichele H, Davidsson P, Blennow K (2003) Cerebrospinal fluid levels of total-tau, phospho-tau and A beta 42 predicts development of Alzheimer's disease in patients with mild cognitive impairment. Acta Neurol Scand Suppl 179:47-51
4. Breteler MMB (2000) Vascular risk factors for Alzheimer's disease: an epidemiologic perspective. Neurobiol Aging 21:153-160
5. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261:921-923
6. Cox R, Bouzekri N, Martin S, Southam L, Hugill A, Golamaully M, Cooper R, Adeyemo A, Soubrier F, Ward R, Lathrop GM, Matsuda F, Farrall M (2002) Angiotensin-1-converting enzyme (ACE) plasma concentration is influenced by multiple ACE-linked quantitative trait nucleotides. Hum Mol Genet 11:2969-2977
7. Feuk L, Prince JA, Blennow K, Brookes AJ (2003) Further evidence for role of a promoter variant in the TNFRSF6 gene in Alzheimer disease. Hum Mutat 21:53-60
8. Gatz M, Pedersen NL, Berg S, Johansson B, Johansson K, Mortimer JA, Posner SF, Viitanen M, Winblad B, Ahlbom A (1997) Heritability for Alzheimer's disease: the study of dementia in Swedish twins. J Gerontol A Biol Sci Med Sci 52: M117-M125
9. Hardy J (1997) Amyloid, the presenilins and Alzheimer's disease. Trends Neurosci 20:154-159
10. Hill WG (1974) Estimation of linkage disequilibrium in randomly mating populations. Heredity 33:229-239
11. Hu J, Igarashi A, Kamata M, Nakagawa H (2001) Angiotensin-converting enzyme degrades Alzheimer amyloid beta-peptide (A beta), retards A beta aggregation, deposition, fibril formation, and inhibits cytotoxicity. J Biol Chem 276:47863-47868
12. Keavney B, McKenzie CA, Connell JM, Julier C, Ratcliffe PJ, Sobel E, Lathrop M, Farrall M (1998) Measured haplotype analysis of the angiotensin-I converting enzyme gene. Hum Mol Genet 7:1745-1751
13. Kehoe PG (2003) The renin-angiotensin-aldosterone system and Alzheimer's disease? J Renin Angiotensin Aldosterone Syst 4:80-93
14. Kehoe PG, Russ C, McIlroy S, Williams H, Holmans C, Liolitsa D, Vahidassr D, Powell J, McGleenon B, Liddell M, Plomin R, Dynan K, Williams N, Neal J, Cairns NJ, Wilcock G, Passmore P, Lovestone S, Williams J, Owen MJ (1999) Variation in DCP1, encoding ACE, is associated with susceptibility to Alzheimer disease. Nat Genet 21:71-72
15. Kehoe PG, Katzov H, Feuk L, Bennet AM, Johansson B, Wiman B, Faire U de, Cairns NJ, Wilcock GK, Brookes AJ, Blennow K, Prince JA (2003) Haplotypes extending across ACE are associated with Alzheimer's disease. Hum Mol Genet 12: 1-9
16. Li YJ, Scott WK, Hedges DJ, Zhang F, Gaskell PC, Nance MA, Watts RL, Hubble JP, Koller WC, Pahwa R, Stern MB, Hiner BC, Jankovic J, Allen FA Jr, Goetz CG, Mastaglia F, Stajich JM, Gibson RA, Middleton LT, Saunders AM, Scott BL, Small GW, Nicodemus KK, Reed AD, Schmechel DE, Welsh-Bohmer KA, Conneally PM, Roses AD, Gilbert JR, Vance JM, Haines JL, Pericak-Vance MA (2002) Age at onset in two common neurodegenerative diseases is genetically controlled. Am J Hum Genet 70:985-993
17. Niu T, Qin ZS, Xu X, Liu JS (2002) Bayesian haplotype inference for multiple linked singlenucleotide polymorphisms. Am J Hum Genet 70:157-169
18. Prince JA, Feuk L, Howell WM, Jobs M, Emahazion T, Blennow K, Brookes AJ (2001) Robust and accurate single nucleotide polymorphism genotyping by dynamic allele-specific hybridization (DASH): design criteria and assay validation. Genome Res 11:152-162
19. Richard F, Amouyel P (2001) Genetic susceptibility factors for Alzheimer's disease. Eur J Pharmacol 412:1-12
20. Samani NJ, Thompson JR, O'Toole L, Channer K, Woods KL (1996) A meta-analysis of the association of the deletion allele of the angiotensin-converting enzyme gene with myocardial infarction. Circulation 94:708-712
21. Selkoe DJ (1991) The molecular pathology of Alzheimer's disease. Neuron 6:487-498
22. Selkoe DJ (2000) The genetics and molecular pathology of Alzheimer's disease: roles of amyloid and the presenilins. Neurol Clin 18:903-922
23. Small GW (1986) Age at onset versus age at examination of Alzheimer-type dementia. Am J Psychiatry 143:271-272
24. Soubrier F, Martin S, Alonso A, Visvikis S, Tiret L, Matsuda F, Lathrop GM, Farrall M (2002) High-resolution genetic mapping of the ACE-linked QTL influencing circulating ACE activity. Eur J Hum Genet 10:553-561
25. Tanzi RE, Bertram L (2001) New frontiers in Alzheimer's disease genetics. Neuron 32:181-184
26. Weeks DE, Lathrop GM (1995) Polygenic disease: methods for mapping complex disease traits. Trends Genet 11:513-519
27. Zhu X, Bouzekri N, Southam L, Cooper RS, Adeyemo A, McKenzie CA, Luke A, Chen G, Elston RC, Ward R (2001) Linkage and association analysis of angiotensin I-converting enzyme (ACE)-gene polymorphisms with ACE concentration and blood pressure. Am J Hum Genet 68:1139-1148